Trials / Conditions / B-precursor Acute Lymphoblastic Leukemia
B-precursor Acute Lymphoblastic Leukemia
5 registered clinical trials studyying B-precursor Acute Lymphoblastic Leukemia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia NCT06649006 | Amgen | Phase 1 |
| Active Not Recruiting | Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Ac NCT06054113 | Amgen | Phase 2 |
| Terminated | Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-pre NCT04506086 | Amgen | Phase 4 |
| Unknown | GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL NCT04601584 | AO GENERIUM | Phase 1 / Phase 2 |
| Completed | Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL NCT03123887 | Harbin Hematology and Oncology Institute | — |